The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ward Robert since 2015.
The trader's CIK number is 1595111.
At the time of the last reporting, Ward Robert was the President and CEO of Eloxx Pharmaceuticals, Inc.. (stock ticker symbol ELOX).
Also see all insider trading activities at Eloxx Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | ELOX | 0 | $0 | 0 | $0 | 76,806 | $0 |
2019 | ELOX | 0 | $0 | 0 | $0 | 142,396 | $0 |
2018 | ELOX | 15,000 | $161,600 | 0 | $0 | 213,595 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | RDUS | 0 | $0 | 0 | $0 | 10,000 | $78,000 |
2015 | RDUS | 0 | $0 | 25,000 | $1,569,125 | 30,000 | $234,000 |
1. Eloxx Pharmaceuticals, Inc. (ELOX)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-02-29 | ELOX | Option Ex | 76,806 | .00 | 0 |
2019-12-26 | ELOX | Option Ex | 35,599 | .00 | 0 |
2019-09-26 | ELOX | Option Ex | 35,599 | .00 | 0 |
2019-06-26 | ELOX | Option Ex | 35,599 | .00 | 0 |
2019-03-26 | ELOX | Option Ex | 35,599 | .00 | 0 |
2018-12-26 | ELOX | Option Ex | 213,595 | .00 | 0 |
2018-05-22 | ELOX | Buy | 5,000 | 14.34 | 71,700 |
2018-03-23 | ELOX | Buy | 10,000 | 8.99 | 89,900 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-10-25 | RDUS | Option Ex | 10,000 | 7.80 | 78,000 |
2015-11-23 | RDUS | Option Ex | 25,000 | 7.80 | 195,000 |
2015-11-23 | RDUS | Sale | 25,000 | 62.77 | 1,569,125 |
2015-06-04 | RDUS | Option Ex | 5,000 | 7.80 | 39,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ward Robert (President and CEO of Eloxx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.